These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 1358762
1. Effect of potentiation of cholinergic tone by pyridostigmine on the GH response to GHRH in elderly men. Coiro V, Volpi R, Bertoni P, Finzi G, Marcato A, Caiazza A, Colla R, Giacalone G, Rossi G, Chiodera P. Gerontology; 1992; 38(4):217-22. PubMed ID: 1358762 [Abstract] [Full Text] [Related]
6. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine. Valcavi R, Valente F, Dieguez C, Zini M, Procopio M, Portioli I, Ghigo E. J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770 [Abstract] [Full Text] [Related]
8. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L. J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361 [Abstract] [Full Text] [Related]
9. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. Peñalva A, Carballo A, Pombo M, Casanueva FF, Dieguez C. J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084 [Abstract] [Full Text] [Related]
10. Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans. Barbarino A, Corsello SM, Tofani A, Sciuto R, Della Casa S, Rota CA, Barini A. J Clin Endocrinol Metab; 1991 Jul; 73(1):75-8. PubMed ID: 2045474 [Abstract] [Full Text] [Related]
12. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone. Giusti M, Marini G, Sessarego P, Peluffo F, Valenti S, Caratti C, Giordano G. Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302 [Abstract] [Full Text] [Related]
13. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients. Giustina A, Bossoni S, Bodini C, Cimino A, Pizzocolo G, Schettino M, Wehrenberg WB. Acta Endocrinol (Copenh); 1991 Nov; 125(5):510-7. PubMed ID: 1759540 [Abstract] [Full Text] [Related]
14. Radiation and neuroregulatory control of growth hormone secretion. Ogilvy-Stuart AL, Wallace WH, Shalet SM. Clin Endocrinol (Oxf); 1994 Aug; 41(2):163-8. PubMed ID: 7923820 [Abstract] [Full Text] [Related]
19. GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH. Ross RJ, Tsagarakis S, Grossman A, Nhagafoong L, Touzel RJ, Rees LH, Besser GM. Clin Endocrinol (Oxf); 1987 Dec; 27(6):727-33. PubMed ID: 2901302 [Abstract] [Full Text] [Related]
20. Effects of sex and age on pyridostigmine potentiation of growth hormone-releasing hormone-induced growth hormone release. Corsello SM, Tofani A, Della Casa S, Rota CA, Sciuto R, Colasanti S, Barini A, Barbarino A. Neuroendocrinology; 1992 Aug; 56(2):208-13. PubMed ID: 1407375 [Abstract] [Full Text] [Related] Page: [Next] [New Search]